Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2024 ∙ Nwachukwu, G. Rihan, A. Nwachukwu, E. Uduma, N. Elliott, K. S. Tiruneh, Y. M.

Understanding COVID-19 Vaccine Hesitancy in the United States: A Systematic Review

  • Americas
  • United States of America
  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Petras, M. Janovska, D. Lomozova, D. Franklova, M. Dlouhy, P. Rosina, J. Lesna, I. K.

Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: A meta-regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Pontiroli, A. E. Scovenna, F. Carlini, V. Tagliabue, E. Martin-Delgado, J. Sala, L. Tanzi, E. Zanoni, I.

Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • Pregnant women
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Price, O. Swanton, R. Grebely, J. Hajarizadeh, B. Webb, P. Peacock, A. Dore, G. J. Cowie, B. C. Vickerman, P. Degenhardt, L.

Vaccination coverage among people who inject drugs: A systematic review

  • All age groups
  • COVID-19
  • Hepatitis A
  • Hepatitis B
  • Human papillomavirus (HPV)
  • Influenza
  • Pneumococcal disease
  • Tetanus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Pereira, A. Pinho, C. Oliveira, A. Santos, R. Felgueiras, M. Martins, J. P.

Vaccination Promotion Strategies in the Elderly: Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Kontandreopoulou, C. N. Solomou, E. E. Kolorizos, E. Diamantopoulos, P. T.

Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Dhamayanti, M. Andriyani, R. Moenardi, S. Karina, P. P.

Vaccine hesitancy in adolescents regarding COVID-19 vaccination: A literature review

  • Adolescents
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Alie, M. S. Abebe, G. F. Negesse, Y. Adugna, A. Girma, D.

Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis

  • Africa
  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, March 2024: conclusions and recommendations

  • Meeting report
  • Poliomyelitis
  • Hepatitis E
  • COVID-19
  • Mpox
  • RSV (Respiratory syncytial virus)
2024 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations

  • Meeting report
  • RSV (Respiratory syncytial virus)
  • Rubella
  • Poliomyelitis
  • COVID-19
  • Cholera
  • Mpox
Download:
Loading...